BTIG Research has recently resumed Blackstone Mortgage Trust Inc (BXMT) stock to Buy rating, as announced on July 19, 2024, according to Finviz. Earlier, on June 25, 2024, Wolfe Research had initiated ...
BTIG lowered the firm’s price target on Outlook Therapeutics (OTLK) to $9 from $50 and keeps a Buy rating on the shares. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback